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Gestational diabetes mellitus (GDM) is defined by the American Diabetes Association 
(ADA) as “diabetes diagnosed in the second or third trimester of pregnancy that was not 
clearly overt diabetes prior to gestation.”1 According to the Centers for Disease Control 
Pregnancy Risk Assessment Monitoring System, the estimated prevalence of GDM in 
the United States was between 4.6 and 9.2% of live births in 2010.2 2007-2014 data 
from the National Health and Nutrition Examination Survey (NHANES) show an 
estimated prevalence of 7.6%.3 Risk factors for GDM include body mass index (BMI) 
>25, less than recommended weight gain during pregnancy, maternal age over 25 years 
old, 1st degree family history of diabetes, higher parity (3 or more live births), previous 
pregnancy with GDM, or belonging to an ethnic group with increased risk for type 2 
diabetes mellitus (T2DM) (Hispanic, Native American, South or East Asian, African 
American, or Pacific Islands descent).3–5 In essence, the majority of pregnant women 
have at least one risk factor for GDM. Factors that lower the risk of GDM include the 
inverse of these variables (BMI < 25, maternal age < 25 years, no family history of 
diabetes, no previous pregnancies with GDM, white race), in addition to lifestyle factors 
prior to pregnancy such as not smoking, participating in 150 minutes or more of physical 
activity per week, and consuming a healthy diet.5,6 
GDM poses significant health risks to the mother and the child. Women with GDM are 
more likely to experience preeclampsia and cesarean delivery, and their infants are 
more likely to have macrosomia, large for gestational age (LGA), neonatal 
hypoglycemia, intensive neonatal care, premature delivery, hyperbilirubinemia, high 
cord blood serum c-peptide, shoulder dystocia or birth injury, and even experience 
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perinatal mortality.7–10 The relationship between maternal blood glucose and neonatal 
adiposity is positive and linear; the risk for birth complications and shoulder dystocia - 
more common among macrosomic/LGA infants - can be attenuated with blood glucose 
management during pregnancy.7 NHANES data estimates that 19.7% of women with 
GDM will later develop T2DM; other data show that this rate is 7-fold greater among 
women who have had GDM compared to women who had normoglycemic 
pregnancies.3,11 For women of racial/ethnic minority groups, particularly black women, 
the risk of T2DM after GDM is elevated further even after controlling for differences in 
BMI.12 
Women who experience GDM are also at increased risk of metabolic syndrome and 
cardiovascular events.13,14 Research on long-term metabolic health of children born 
during a GDM pregnancy is unclear. Some data suggest an increased risk for obesity 
later in childhood or adulthood among women with GDM, but there is also conflicting 
research attributing the risk of childhood obesity to high maternal BMI rather than 
intrauterine exposure to GDM.15–20 Similar observations have been made about risk for 
T2DM and metabolic syndrome in children of women with GDM – in-utero exposure to 
diabetes poses risk for offspring, but maternal pre-gravid BMI may be a higher risk 
factor for metabolic dysfunction than GDM.16,21,22 
In addition to metabolic risk factors, women with GDM are known to experience high 
levels of psychological distress.23,24 Although women with GDM may adapt well 
psychologically to their diagnosis, this stress can impact their ability to comply with self-
management behaviors and predispose them to postpartum depression (PPD).25–28 
Further complicating health risks for women with GDM is a shift in focus from maternal 
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health to solely fetal outcomes, which is contributing to an increase in maternal mortality 
in the US overall.29,30 
Despite these risks, dietary and lifestyle management of GDM shows promise in 
mitigating negative implications for birth outcomes as well as for long-term metabolic 
health of mother and child.7,31–34 In July 2018, the Academy of Nutrition and Dietetics 
(AND) came out with an update to their evidence-based nutrition practice guidelines for 
GDM, in which they review the role of the registered dietitian nutritionist (RDN) in 
providing medical nutrition therapy (MNT) to women with GDM.35 The AND practice 
paper reviews various dietary regimens for managing blood glucose in pregnancy, 
including the highly successful strategies proposed by the research group of Dr. Lois 
Jovanovic and implemented by the California Diabetes and Pregnancy Program 
(CDAPP).36 Of course, other recommendations exist from a variety of sources; one such 
alternative method is proposed by a registered dietitian who has extensive experience 
working with prenatal clients.37 Finding the optimal dietary treatment strategy for a client 
with GDM requires that the RDN be able to both understand the pathophysiology of 
GDM and integrate the knowledge of the metabolic effects of GDM with the many 
psychosocial factors that impact women with high risk pregnancies in the United States. 
The purpose of the present paper is to explore the RDN’s role in balancing optimization 
of short-term pregnancy outcomes with long-term maternal metabolic and mental health 





Pathophysiology and diagnosis of GDM 
Some amount of peripheral insulin resistance is expected in normal pregnancy, which 
functions to increase nutrient transfer to the fetus.38 Insulin sensitivity in normal 
pregnancy has been shown to be negatively correlated with serum levels of placental 
growth hormone, but lower insulin sensitivity has recently been shown to be more 
strongly correlated with both increased fasting triglycerides and leptin and positively 
correlated with increased insulin-like growth factor binding protein-1.39,40 Interestingly, 
when controlling for fasting levels of adipokines in their model, McIntyre et al. found that 
the relationship between maternal BMI and insulin resistance was no longer found to be 
statistically significant – following the logic of the relationship they found between insulin 
resistance and leptin, this is likely because the majority of maternal leptin is produced 
by the placenta and not by adipose tissue.39,41 However, differences in placental leptin 
receptors are present between obese and non-obese women, which may still contribute 
to higher insulin resistance and risk for GDM in obese women.42 Adiponectin may also 
play a role –  in non-obese women, as well as when controlling for adiposity and 
baseline glucose tolerance, pregnant women with low levels of adiponectin in their first 
trimester were found to have higher insulin resistance and be at increased risk of GDM 
later in pregnancy.43,44 
Just like any other form of diabetes, GDM is a condition of hyperglycemia that results 
from a combination of insulin resistance and an inability for pancreatic beta-cells to 
compensate for the body’s insulin needs. As the body becomes more resistant to insulin 
in natural pregnancy progression, insulin requirements to maintain euglycemia are 
elevated; studies show further increases in insulin resistance and lower insulin output 
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when comparing women with GDM to women without GDM both before pregnancy and 
during the third trimester.45–47 While GDM may be an acquired disorder only in 
pregnancy for some women, the fact that many women with GDM show lower serum 
insulin before pregnancy indicates they likely have pre-existing beta-cell dysfunction, 
which is simply discovered upon screening during pregnancy.48 As expressed above, 
the ADA defines GDM as a distinct disorder during pregnancy that is not pre-existing 
Type 1 diabetes mellitus (T1DM) or T2DM.1 However, studies among women with GDM 
show relative prevalence of autoimmune, monogenic, and type-2-like diabetes that 
reflect the prevalence of evolving T1DM, mature-onset diabetes of the young, and 
prediabetes/T2DM in the population as a whole.48 
The diagnosis of GDM is a debated topic, with different diagnostic criteria proposed by 
different expert organizations.1 In general, recommendations are to screen women prior 
to conception or at the first prenatal visit for undiagnosed T1DM or T2DM, and initiate 
blood glucose management with these women immediately.1,49 If there is no overt 
pregestational diabetes, either the one-step or the two-step method is used to diagnose 
GDM at 24-28 weeks of pregnancy, when insulin resistance is at its highest.1 
One-step strategy: perform a 75 g oral glucose tolerance test (OGTT) after an 8 hour 
fast at 24–28 weeks of gestation in women not previously diagnosed with overt 
diabetes. The diagnosis of GDM is made when any of the following plasma glucose 
values are met or exceeded at fasting, 1 hour, or two hours (see Table 1).1 
Two-step strategy: Step 1 is to perform a 50-g glucose loading test in a non-fasting 
state at 24–28 weeks of gestation in women not previously diagnosed with overt 
diabetes. If the plasma glucose level measured 1 h after the load is 130 - 140 mg/dL, 
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proceed to Step 2. In step 2, perform a 100-g OGTT when the patient is fasting. The 
diagnosis of GDM is made if one of the following plasma glucose levels are met or 
exceeded at 1 hour, 2 hours, or 3 hours (see Table 1).1 




Carpenter-Coustan OR National Diabetes Data Group 
Fasting 92 mg/dL 95 mg/dL  105 mg/dL 
1 h 180 mg/dL 180 mg/dL  190 mg/dL 
2 h 153 mg/dL 155 mg/dL  165 mg/dL 
3 h  140 mg/dL  145 mg/dL 
 
The ADA does not take a clear stance on which GDM screening criteria should be used, 
but suggests with adequate prenatal care, the 1-step method may be the most 
beneficial and cost-effective.1 Some other research suggests that an A1c of >5.7%, 
which is indicative of pre-gestational prediabetes, may be particularly useful in 
identifying more women with mild GDM who would benefit from treatment.50–52 
Depending on the etiology of her GDM and other biological factors, each woman’s 
specific response to dietary carbohydrates may vary.35 Results from studies using 
continuous glucose monitoring systems show elevated post-breakfast morning blood 
glucose – consistent with higher insulin resistance in the morning in diabetes outside of 
pregnancy, commonly known as the dawn phenomenon – as well as impaired early-
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phase insulin secretion leading to higher postprandial blood glucose compared to non-
diabetic pregnant women.53,54 
Fructose is a common culprit for causing or worsening T2DM. As will be discussed in 
the next section, fructose from fruit and added sugar are often suggested to be limited in 
MNT strategies for GDM, particularly at breakfast.36 In glycolysis, the rate-limiting step is 
the conversion of fructose-6-phosphate to fructose-1,6-bisphosphate by 
posphofructokinase – dietary fructose bypasses this step and is metabolized by 
fructokinase into fructose-1-phosphate, leading to more rapid production of the 
metabolites glyceraldehyde and dihydroxyacetone-phosphate than when glucose is 
metabolized.55 This is a basic pathway in general human nutritional biochemistry, but is 
important to note in considering the potential effectiveness of the dietary management 
strategies outlined in this paper. 
Efficacy of dietary management strategies for GDM 
“Success” in GDM blood glucose management is defined by consistently meeting blood 
glucose targets for GDM as outlined by the ADA in the table below.49 However, there is 
some debate as to whether these targets are low enough to prevent risks associated 
with GDM.  A 2011 systematic review found evidence to suggest lower fasting blood 
glucose targets, and called for further trials to be conducted on optimal postprandial 
targets.56 The CDAPP also uses targets lower than suggested by the ADA, and guides 
practitioners to not use 2 hr postprandial blood glucose targets, as post-meal glycemic 
peaks occur on average at 1 hr after beginning a meal and are most closely correlated 
with poor fetal outcomes.36 These targets are compared in Table 2. 
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Table 2. Comparison of blood glucose targets for GDM36,49,56 
 ADA 2018 Hernandez et al. 2011* CDAPP 2015 
Fasting < 95 mg/dL  < 81 mg/dL <90 mg/dL 
Premeal/bedtime/overnight   60-99 mg/dL 
Postprandial, 1-hr < 140 mg/dL <122 mg/dL 100-129 mg/dL 
Postprandial, 2-hr < 230 mg/dL <110 mg/dL  
Mean daily glucose   87-100 mg/dL 
*based on mean blood glucose measurements seen in normal pregnancies 
The AND endorses the 2016 ADA guidelines (this current paper references the 2018 
ADA guidelines, but recommended blood glucose targets have not changed), as these 
are backed by the Fifth International Workshop-Conference on Gestational Diabetes 
Mellitus.57 Given that there is a lack of consensus in diagnostic criteria and blood 
glucose targets after diagnosis, it is no surprise that researchers and clinicians promote 
a wide variety of dietary approaches for optimal blood glucose management in GDM.   
AND Evidence Based Nutrition Practice Guidelines for GDM 
The AND practice paper is a systematic review covering several key questions 
determined by an expert panel of GDM nutrition practitioners and researchers.35 The 
structure of the paper follows the Nutrition Care Process (assessment, diagnosis, 
intervention, monitoring and evaluation), making it simple for an RDN to apply in 
practice. As expected for a paper coming from the professional organization for RDNs, 
their very first recommendation is to refer all women diagnosed with GDM to an RDN for 
MNT, a guideline that is supported by both the ADA and the Endocrine Society.49,58 The 
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panel then endorses that an RDN complete each specific step of the Nutrition Care 
Process with every GDM client they are referred – this is simply a standard of clinical 
practice for every patient seen by an RDN, but nonetheless it is important to advocate 
that a qualified nutrition provider be involved in each of these steps when caring for a 
woman with GDM. 
The practice paper proceeds to then analyze the evidence for different dietary 
recommendations, ascribing an evidence rating (strong, fair, weak, consensus, or 
insufficient evidence) to each dietary strategy. Table 3 shows a breakdown of strategies 
that received each rating, with a brief description of what each rating means.59 There 













Table 3. Ratings for specific recommendations from the AND35,59 





Refer to an RDN for MNT. 
RDNs should implement MNT for GDM. 
Encourage physical activity for at least 30 minutes every day, 
unless contraindicated. 




but remain alert for 
new information 





RDNs should individualize kcal prescriptions based on daily 
reference intakes (DRI) and Institute of Medicine guidelines.  
RDNs should individualize the amount and type of carbohydrate 
(CHO) for women with GDM – not enough evidence exists for a 
specific CHO goal for all women with GDM; low to medium 
glycemic index (GI) diets (<55-99) and DASH diets show 
positive outcomes. 
RDNs should individualize amount and type of CHO at 
breakfast – shifts to lower CHO or lower GI breakfasts may help 
some women; no studies support restricting individual foods like 












or lack of controlled 
trials in the 
literature; 
practitioners should 




RDNs should complete assessments including anthropometric, 
biochemical, and medical data as well as nutrition-focused 
physical findings and client history for women with GDM. 
RDNs should provide regular and frequent MNT visits – 1 initial 
60-90 minute visit, a 30-45 minute follow-up within 1 week, 
another 15-45 minute follow up within 2-3 weeks, and additional 
follow-ups as needed or until the end of the pregnancy. 
RDNs should provide adequate macronutrients to support 
pregnancy based on nutrition assessment and with guidance 
from the DRIs: minimum 175 g CHO, minimum 71 g protein 
(1.1g/kg/d), and 28 g fiber. 
RDNs should encourage adequate vitamin and mineral intake 
through healthy food choices, with emphasis on iron, folate, 
calcium, vitamin D, choline, and iodine. 
RDNs should recommend daily use of a prenatal 
multivitamin/multimineral supplement to meet the DRIs for 
pregnancy, and any additional supplements to address 
inadequate intake or micronutrient deficiency. 
RDNs should distribute total kcals and CHO into smaller meals 
and snacks throughout the day – 3 meals and 2 snacks may 




RDNs should guide women with GDM who choose to use 
artificial sweeteners to choose only those approved by the FDA 
or generally recognized as safe (saccharin, aspartame, 
acesulfame potassium, sucralose, neotame, advantame, steviol 
glycosides, and monk fruit extract). 
RDNs should reinforce abstinence from alcohol during 
pregnancy. 
RDNs should monitor and evaluate food and nutrition-related 
history outcomes, anthropometric measurement outcomes, and 
biochemical data, medical tests, and procedure outcomes 
including self-monitoring of blood glucose (SMBG) records and 
ketone testing records. 
 
As evidenced by the recommendations in the table above, the AND working group 
found mixed evidence for specific dietary recommendations beyond traditional nutrition 
recommendations for pregnancy. Their synthesis points practitioners towards 
individualization based on patient assessment, monitoring, and preference, and 
conclude that “more information is needed to determine optimal calorie levels, amount 
and types of macronutrients, and distribution of meals and snacks for optimal clinical 





CDAPP and Jovanovic/Euglycemic Diet Recommendations for GDM 
The CDAPP is a program for all women with diabetes in pregnancy developed through 
the California Department of Public Health, and is greatly influenced by the 
endocrinologist and diabetes in pregnancy researcher, Dr. Lois Jovanovic.36 Because 
most of Dr. Jovanovic’s nutrition research papers were published before the year 2000, 
they were excluded during the AND’s systematic review, except for one paper which 
reviews fasting blood glucose in early pregnancy for women with diabetes.60 
The Jovanovic or Euglycemic diet for GDM is low GI, and fairly low carbohydrate diet – 
overall 40% CHO, 20% protein, 20% fat.60 It also includes specific macronutrient 
recommendations for meals (Table 4.)61  
Table 4. Jovanovic/Euglycemic Diet Carbohydrate Percentage by Meal61 
Target postprandial blood 
glucose 
<140 mg/dL <120 mg/dL 
Breakfast <45% <33% 
Lunch <55% <45% 
Dinner <50% <40% 
 
The Jovanovic/Euglycemic diet is the basis of the CDAPP, and is also implemented at 
the Sansum Diabetes Research Center in Santa Barbara, CA. In North Carolina, Dr. 
Edith Miller, an endocrinologist who worked closely with Dr. Jovanovic and is now 
medical director of the Carolinas Diabetes Center, oversees its implementation through 
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the meals served to hospitalized obstetric patients with GDM at Atrium Health and in the 
MNT provided to women with GDM at the Carolina Diabetes Center in Charlotte, NC.  
The CDAPP guides RDNs to provide meal plans to clients with GDM that have a 
minimum of 175 g CHO per day, as this is the DRI for pregnancy, and less than 45% 
kcals from CHO, distributed between 3 meals and 2 to 4 snacks with a lower CHO 
breakfast (15-30 g).36 The guidelines emphasize a low GI diet, and recommend 
excluding fruit juices, fruits, milk, ready-to-eat or instant cereals, bagels, croissants and 
rice porridge from breakfast. Snacks are to contain a lower amount of carbohydrate than 
lunch and dinner and should occur 2-3 hours after or before a meal; snacks should not 
contain both fruit and milk. Bedtime snacks with 7 g of protein and 15-30 g CHO are 
recommended no more than 10 hours before breakfast the following morning to prevent 
middle-of-the-night hypoglycemia, starvation ketosis, and to suppress hepatic glucose 
output in response to low blood glucose. RDNs should tailor their approach to the client, 
and may use carbohydrate counting methods, or visuals such as the California MyPlate 
for Gestational Diabetes.36 
There is no reference provided in the CDAPP guidelines for why fruits or milk should be 
excluded at breakfast. In observation of nutrition counselling at the Carolinas Diabetes 
Center, the registered dietitians claimed that in practice the avoidance of fruit at 
breakfast seemed to drastically help postprandial blood glucose in the morning but were 
unsure why this worked. While the AND found no evidence that fruit or milk should be 
excluded at breakfast, theoretically it is possible that the fructose content of fruit, and in 
other foods high in fructose because of added sugar, raises blood glucose more than 
lower fructose foods because of the pathway explained in the previous section.55 In the 
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literature, the effect of fructose on blood sugar is conflicting, and may only have a 
negative effect when it causes an increase in caloric consumption overall.62,63 However, 
other research does show that fructose is metabolized primarily in the liver, and large 
influxes of fructose result in increased de novo lipogenesis and elevated serum 
triglycerides, which can lead to insulin resistance in the long term – still, the majority of 
fructose in Western diets comes from added sucrose, not fruit.64 Furthermore, the 
benefits of fiber and high micronutrient content of fruits, especially in low GI fruits like 
berries and grapefruit, may make them a beneficial food to incorporate as part of a 
lower carbohydrate breakfast; a similar approach could be applied to incorporate protein 
and micronutrient-rich milk at breakfast. 
“Real Food” for GDM 
Real Food for Gestational Diabetes: An effective alternative to the conventional nutrition 
approach is a book written by Lily Nichols RDN, CDE, who was also involved in the 
development of the CDAPP.37 Nichols also authored Real Food for Pregnancy: The 
science and wisdom of optimal prenatal nutrition, which focuses on general prenatal 
nutrition and prevention of GDM.65  In the beginning of her books, Nichols calls her 
approach “evidence-based;” while she most certainly does cite a lot of credible literature 
throughout the book, a good amount of her recommendations come from anecdotes 
and observations from clinical experience – she claims that in the perinatology clinic she 
worked in, they were able to reduce the amount of women with GDM dependent on 
insulin and medication by half, and saw better birth outcomes, using her real food 
approach.65 When the author was contacted to inquire about whether any clinical trials 
had been conducted on this approach, she replied that none had been done, but that 
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she was in talks with a large research university about a clinical trial that would 
hopefully provide results in the next 5 years. Because there is not yet clinical data to 
back up Nichols’ specific approach, it will be considered as practice-inspired instead of 
evidence-based. 
Nichols defines “real food” as food that is “obtained locally and eaten in its natural, 
unprocessed form.”65 Nichols points out that current nutrition science tends to be very 
nutrient-focused, while traditional pregnancy wisdom tends to be very whole-food 
focused. Her approach goes beyond just carbohydrates – she claims that the 
conventional guidelines provided by the AND are “devoid” of nutrients, and that a lower 
CHO diet with plenty of whole foods and focus on animal-sourced proteins can help 
prevent GDM or improve blood glucose management for women who do have GDM.37,65 
Instead of meticulous carbohydrate counting and portion measuring, Nichols 
recommends a combination of mindful eating strategies along with the Plate Method: 
“Aim for half of your plate to come from non-starchy vegetables, one quarter of your 
plate from proteins and fats, and the remaining one quarter to come from carbohydrates 
(generally no more than 1 cup total, or 30 grams of carbohydrates, at one sitting). Some 
women may need less than 30 grams of carbohydrates per meal to maintain normal 
blood sugar.”37 She suggests 15 g of CHO at breakfast, and recommends individualized 
testing of blood glucose response to fruit and milk in the morning. She also advocates 
for small frequent meals and snacks in accordance with hunger and fullness cues. 
Nichols emphasizes avoiding refined carbohydrates, added sugar, trans fats and 
artificial sweeteners. Instead, the real food approach focuses on low GI CHO sources 
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with more protein and fat – both saturated and “non-inflammatory” unsaturated fats (oils 
rich in omega-3 fatty acids instead of those rich in omega-6 fatty acids).  
Nichols provides meal plans for a daily total of 90, 120, and 150 g CHO, stating that the 
DRI of 175 g CHO for pregnant women is outdated and rooted in a fear of ketosis that is 
not evidence-based. An entire chapter is focused on why nutritional ketosis is often 
confused with diabetic ketoacidosis, how modest amounts of ketones in the urine do not 
reflect ketones in the blood, and how ketone bodies are a normal part of a healthy 
pregnancy, and could even be beneficial to the fetus.37,66,67 Her argument for how 
ketosis could be healthy for the mother is that in obese women, minimal weight gain and 
even weight loss has been associated with better pregnancy outcomes, and this may be 
difficult to achieve without some level of ketosis.68 However, as cited earlier in this 
paper, less than recommended weight gain in pregnancy is associated with a higher risk 
of GDM even when controlling for BMI.4 
While Nichols has years of clinical experience to back up her claim that a low-carb, “real 
food” approach is safe and highly effective for pregnant women with GDM, there is a 
lack of evidence to back up her claims. Furthermore, the AND provides evidence that 
higher CHO diets may be just as effective for blood glucose control in GDM.35 However, 
encouraging adequate protein and micronutrient consumption from locally sourced 






Psychological impacts of GDM and its treatment 
The AND practice paper notes the importance of considering a woman’s psychosocial 
situation during assessment, monitoring and evaluation in MNT for GDM.35 Women with 
GDM experience elevated psychological distress, which manifests as anxiety about the 
outcomes of the condition, and stress related to the pressure to fulfill multiple roles and 
a disconnect between diabetes management strategies and cultural practices.23,24 
Women with GDM are at an increased risk for PPD, which may be a result of maternal 
psychological and physiological stress.26,28 Low-income women with GDM are at an 
even higher risk of experiencing PPD; they “expressed shock and disappointment over 
diagnoses and highlighted need for psychological support from health care 
professionals.”27,69 
For women with past or active eating disorders, the physical and mental health risks 
during pregnancy are high. One study showed that 22% of women with a past eating 
disorder had a relapse during pregnancy, and another study demonstrated that women 
with active bulimia nervosa during pregnancy are more likely to experience both GDM 
and PPD.70,71 Risk factors for eating disorders are a complicated combination of 
psychological, sociocultural, and biological factors, but distinctively include a 3-way 
relationship between depression, body dissatisfaction, and dieting.72,73 To prevent the 
onset or worsening of eating disorder behaviors in clients with GDM, the RDN must be 





An ethical dilemma in maternal nutrition care 
In observation of MNT provided by RDNs at the Carolina Diabetes Center, there was an 
intense focus on fetal outcomes, even at the cost of limiting the normal enjoyment of 
foods. For example, an Israeli patient was told that she could not eat dates at all during 
the remainder of her pregnancy because of their sugar content – this left the patient 
feeling distraught and discouraged that a culturally familiar food would be eliminated for 
the sake of extreme precaution in avoiding macrosomia. These observations are 
corroborated by the results of a qualitative study on perspectives of women with GDM 
which revealed themes of “the disrupted pregnancy, projected anxiety, reproductive 
asceticism, women as baby machines, perceived stigma, lack of shared understanding 
and postpartum abandonment.”74 The researchers from this study found that this focus 
on a woman’s body solely as a means to produce a healthy infant led some participants 
to be less inclined to care for their own physical and mental health.74 This study in 
particular brings to light the need of the health care team to view the mother as an 
autonomous individual with her own physical and mental health care needs. 
Furthermore, as stated earlier in this paper, the research is not actually clear on the 
long-term health risks of children born to women with GDM.15–22,31 Placing such high 
importance on fetal outcomes may be putting unnecessary strain on women with GDM, 
and further propelling the concerns noted by Parsons et al. 
The theme of prioritizing fetal outcomes over maternal health is common in maternal-
fetal medicine as a whole; even as the infant mortality rate in the US has dramatically 
improved in the last century, maternal mortality has increased in the last decade by 
26%.29,30 To put this statistic in perspective, international rates of maternal mortality 
Caldwell 22 
 
have decreased, and the rate of maternal mortality among non-hispanic black women in 
the US is three to four times higher than the rate for non-hispanic white women.29,30  
The code of ethics for RDNs focuses on four principles: autonomy, non-maleficence, 
beneficence, and justice.75,76 In the ethical dilemma of balancing maternal and fetal 
outcomes in a case of GDM, it is imperative that the RDN take a holistic approach to 
ethical decision making. This means acknowledging the pre-existing mental health 
issues of eating disorders and PPD among the GDM population, weighing the risks and 
benefits of a strict dietary regimen during pregnancy, allowing the patient to bring their 
autonomous needs and desires to the decision-making process, and lastly paying 
specific attention to personal and systemic biases that contribute to maternal health 
disparities among women of racial/ethnic minorities and women in larger bodies.77 
RDNs can play an impactful role in improving maternal health outcomes in the US by 
taking an approach to ethical MNT that cares for the whole mother – body and mind. 
 
Implications for practice 
After acknowledging internal biases and making a commitment to an ethical, holistic 
approach, the RDN can weigh the evidence presented in this paper to decide which 
strategies will be most beneficial in the short and the long term for each individual client 
with GDM. Because evidence shows that different strategies may work for different 
clients, it is important that the RDN be flexible in changing the diet prescription when 
necessary – less than ideal blood glucose control may not always be a result of “non-
compliance,” and could be rather an issue of intervention tailoring on behalf of the 
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provider.35 Women with GDM are considered to be highly-motivated clients; fostering 
this motivation with continued encouragement of SMBG can help improve GDM 
management.78 
After birth, the RDN should continue to follow up with the client to help instill lifestyle 
habits that prevent T2DM.11,35,49,79 A study in a cohort of ethnically diverse, low-income 
women showed low perception of risk for developing T2DM after giving birth – 
counselling approaches that take into account cultural and health literacy 
appropriateness are of utmost importance.69 Furthermore, prenatal nutrition care that 
includes counselling on diet, exercise and future diabetes risk may enhance postpartum 
diabetes screening.34 On a systems level, only about half of women who have GDM in 
pregnancy are screened for T2DM in their postpartum visits; RDNs should continue to 
follow-up with their clients after delivery and also act as an advocate for their patients in 
requesting consistent T2DM screening in postpartum.80 Studies on barriers to follow-up 
with an RDN after birth specifically in the GDM population in the US are sparse; 
possible barriers that should be explored in future research include potentially low initial 
referral rates or low approved units of MNT by the referring provider, lack of Medicaid 
coverage for pregnancy services after delivery, low perception of risk for T2DM as noted 
by Singh et al, or general barriers to accessing care such as transportation and 
language differences. RDNs should also promote and support breastfeeding. Women 
with GDM have lower continuation rates of breastfeeding compared to non-diabetic 
women, but longer breastfeeding duration in women with GDM is associated with lower 
rates of progression to T2DM.81,82 
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A focus on modifiable behaviors versus weight may serve double duty in preventing 
disordered eating and improving physical maternal health outcomes. Both mindful and 
intuitive eating strategies emphasize interoceptive awareness of hunger and fullness 
and de-emphasize focus on weight changes.83 Mindful eating and movement strategies 
can improve glycemic control for women with GDM during their pregnancies, and also 
help prevent T2DM after giving birth.33,84 In addition, intuitive eating is associated with 
lower overall BMI and lower odds of disordered eating behaviors.85 It may be a helpful 
tool in both preventing the development or recurrence of eating disorders, as well as in 
helping to manage blood glucose during pregnancy, postpartum, and beyond.86,87  
 
Conclusion 
In conclusion, there are multiple dietary strategies that may be effective for optimal 
blood glucose control in women with gestational diabetes; lower carbohydrate 
strategies, especially those that provide less than the DRI of carbohydrate for pregnant 
women, may not have a greater benefit than higher but consistent carbohydrate diets 
that still provide adequate fiber, protein, and micronutrients. Using clinical judgment, 
compassion, and principles of ethical care, the registered dietitian nutritionist can 
choose an approach that optimizes fetal outcomes without compromising maternal 
mental and physical health. Methods that utilize mindful and intuitive eating may be 
highly effective in achieving this balance and can also be tailored to instill lifestyle 
behaviors that prevent type 2 diabetes in the long term. The role of the registered 
dietitian nutritionist is clear on the interdisciplinary team – multiple professional 
organizations advocate for medical nutrition therapy provided by a registered dietitian 
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nutritionist in the treatment of gestational diabetes. Moving forward, registered dietitian 
nutritionists in the maternal and child health field should seek to increase referral rates 
from obstetricians for medical nutrition therapy through local and national advocacy 
initiatives and continue to follow up with patients after delivery to establish health 
promoting behaviors individualized to each new mother’s life. With ethical nutrition care, 
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